Control of Hepatitis C: A Medicinal Chemistry Perspective
- 9 December 2004
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 48 (1), 1-20
- https://doi.org/10.1021/jm0400101
Abstract
No abstract availableThis publication has 87 references indexed in Scilit:
- Substrate Complexes of Hepatitis C Virus RNA Polymerase (HC-J4): Structural Evidence for Nucleotide Import and De-novo InitiationJournal of Molecular Biology, 2003
- EsomeprazoleDrugs, 2002
- The solution structure of the N-terminal proteinase domain of the hepatitis C virus (HCV) NS3 protein provides new insights into its activation and catalytic mechanismJournal of Molecular Biology, 1999
- Interferon (IFN)-α Activation of Human Blood Mononuclear Cells In Vitro and In Vivo for Nitric Oxide Synthase (NOS) Type 2 mRNA and Protein Expression: Possible Relationship of Induced NOS2 to the Anti–Hepatitis C Effects of IFN-α In VivoThe Journal of Experimental Medicine, 1997
- Novel Hepatitis C Virus Protease Inhibitors: Thiazolidine DerivativesBiochemical and Biophysical Research Communications, 1997
- In vivo translational efficiency of different hepatitis C virus 5′‐UTRsFEBS Letters, 1997
- Genetic Analysis of Internal Ribosomal Entry Site on Hepatitis C Virus RNA: Implication for Involvement of the Highly Ordered Structure and Cell Type-Specific Transacting FactorsVirology, 1997
- A Zinc Binding Site in Viral Serine ProteinasesBiochemistry, 1996
- Expression and characterization of hepatitis C virus proteins.Uirusu, 1995
- On the size of the active site in proteases. I. PapainBiochemical and Biophysical Research Communications, 1967